Sarah Hosback

First-in Man, Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia (AML) in CR at High Risk for Early Relapse

A. Roberts, B. Smith, S. Busfield, 2014 .

A Phase 1 and Correlative Biological Study of CSL360 (anti-CD123 mAb) in AML

I. Lewis, P. Marlton, A. Roberts, 2008 .